Open Label Randomized Clinical Trial to Assess the Safety of Teleconsultation

Launched by CONSORCI SANITARI DE L'ALT PENEDÈS I GARRAF · Oct 14, 2021

Keywords

ClinConnect Summary

This clinical trial is studying the safety of remote consultations, like video or phone appointments, for patients who need follow-up care in a hospital setting. The researchers want to see if these remote consultations are as safe as traditional face-to-face visits when it comes to managing patients' ongoing health issues. A total of 2,136 patients will be divided into three groups: one group will have in-person visits, while the other two groups will use remote consultations.

To be eligible for the remote consultations, patients need to be able to use the required technology, such as video conferencing tools, and must have a health condition that doesn't require physical exams. Patients with certain communication challenges or those involved in other clinical trials will not be included. During the study, participants can expect to have at least three visits, including an initial screening and follow-ups over the course of a year. This trial is currently recruiting participants of all ages and genders, and it aims to ensure that remote care can safely meet patients' health needs.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Men and women of any age.
• • Possibility of making consultations by telephone, at the discretion of the investigator, taking into account the severity and complexity of the baseline pathology and the objective of health care.
• • Forecast to carry out follow-up in external consultation.
• • Agreement to be attended through a non-face-to-face system.
• • Ability to connect to the video consultation system.
• • Device compatible with the video consultation system.
• • Possibility of collaborating in the necessary evaluations.
• • Legal capacity to give informed consent.
• • Signature of the informed consent for inclusion of the study.
• Exclusion Criteria:
• • Need to carry out physical examinations, visualize the patient in person or perform techniques that involve face-to-face visits.
• • Need for face-to-face consultation due patient's clinical situation.
• • Follow-up by more than three medical specialists.
• • Visual, hearing or functional impairments that may hamper patient-physician communication.
• • Patients enrolled in another clinical trial that requires an experimental intervention during the follow-up.